Corcept Therapeutics (CORT)
Develops cortisol-modulating medicines for endocrine disease and cancer.
$115.65
vs last close−1.86 (−1.58%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 77.27% | 83.52M shares | |
|---|---|---|---|
| 451 holders · as of Jun 30, 2026 | |||
| Insiders | 18.62% | 20.13M shares | |
| 11 holders · as of Sep 18, 2026 | |||
| Other | 4.11% | 4.44M shares | |
| remainder | |||
108.10M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
451 holders · 83.52M shares · 131 new positions · 279 increased · 114 reduced · 52 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 12.43M | 11.50% | +280.7K | Aug 7, 2026 |
| Ingalls & Snyder LLC | 7.93M | 7.34% | +325.8K | Aug 14, 2026 |
| Renaissance Technologies LLC | 5.26M | 4.87% | −421.2K | Aug 13, 2026 |
| Vanguard Portfolio Management LLC | 5.04M | 4.67% | +224.1K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 4.17M | 3.86% | +95.3K | Aug 13, 2026 |
| Parallel Advisors, LLC | 3.96M | 3.67% | −15.2K | Aug 5, 2026 |
| FMR LLC | 3.34M | 3.09% | +147.4K | Aug 13, 2026 |
| State Street Corp | 3.28M | 3.03% | +78.4K | Aug 7, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 10.90% | 11.54M | 13G | Jul 17, 2025 |
| Ingalls & Snyder LLC | 7.80% | 8.17M | 13G | Feb 21, 2025 |
| Joseph K. Belanoff | 6.30% | 6.82M | 13G | Feb 14, 2025 |
| Renaissance Technologies LLC | 5.47% | 5.76M | 13G | Feb 12, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 16, 2026 | Roberto Wandenkolk Vieiraofficer: President, Oncology | Sale | 296 | $100.82 | 3,946 |
| Sep 15, 2026 | James N. Wilsondirector | Sale · 3 lots | 10,000 | $110.69 | 1,064,543 |
| Sep 14, 2026 | Joseph Douglas Lyonofficer: See Remarks | Sale · 2 lots | 10,000 | $113.49 | 5,683 |
| Sep 1, 2026 | Sean Maduckofficer: See Remarks | Sale · 3 lots | 25,000 | $114.43 | 9,755 |
| Sep 2, 2026 | Roberto Wandenkolk Vieiraofficer: President, Oncology | Sale · 7 lots | 58,333 | $110.76 | 4,242 |
| Aug 26, 2026 | Kimberly Parkdirector | Sale | 26,685 | $122.55 | 0 |
| Aug 25, 2026 | Sean Maduckofficer: See Remarks | Sale · 2 lots | 30,955 | $125.58 | 9,755 |
| Aug 18, 2026 | David L. Mahoneydirector | Sale · 4 lots | 103,606 | $118.25 | 1,133,539 |
| Aug 17, 2026 | Gary Charles Robbofficer: Chief Business Officer | Sale | 10,000 | $116.26 | 39,716 |
| Aug 14, 2026 | James N. Wilsondirector | Sale · 3 lots | 10,000 | $111.43 | 1,074,543 |
House and Senate disclosures
Not reported.